Novel pharmaceutical/cosmetic compositions contain at least one biaromatic
ligand activator of a PPAR receptor, such biaromatic ligand having the structural
formula (I):
##STR1##
and are well suited, inter alia, for regulating and/or restoring skin lipid metabolism,
for treating a wide variety of dermatological afflictions, and for preventing and/or
treating the signs of aging and/or dry skin.